Project Details
| Status | Active |
|---|---|
| Effective start/end date | 9/09/26 → 17/09/31 |
Clinical Trial Phase
- Phase III (a & b)
A Phase III, Open-Label, Randomised, Multicentre, Global Study of Adjuvant Datopotamab Deruxtecan in Combination With Rilvegostomig in Participants With High-risk Muscle Invasive Urothelial Carcinoma (TROPION-Urothelial04)
- Herbison, Harriet (Primary Chief Investigator (PCI))
Project: Research